Pulse Biosciences Inc - רווח נקי למניה בארבעת הרבעונים האחרונים PLSE

Pulse Biosciences, Inc. (PLSE) develops innovative nanosecond pulsed systems at its US centers. The trailing twelve months (TTM) earnings per share growth rate, with GURU.Markets data illustrated on this chart, recorded a metric value of -6.20. However, a single-product dependence on one platform and the capital requirements for launch, combined with clinical trial outcomes, create significant regulatory risks.
Pulse Biosciences Inc - פילוחים אנליטיים ומדדי מפתח (PLSE)

The long-term reliability of Pulse Biosciences, Inc. (PLSE) is determined by its ability to scale net income, as reflected by the rolling annual EPS change via the percentage growth in earnings per share over the last four quarters. This trend captures the effectiveness of diversifying component supply chains and equipment assembly, directly linking operational resilience against chip shortages to the growth of shareholder value.